Archive

Hello, my name is Oana Leonte, and I work in the Business Support Team at Lhasa Limited as a Business Support Manager.

In my role I provide support to many different functions across the organisation, this includes our Marketing, Applied Sciences and Business Partnerships teams. My role is very varied and relies on attention to detail and organisational skills to accommodate travel bookings and events planning, amongst other areas of support.

Read on to discover what a day in the life of a Business Support Manager at Lhasa can look like!

Mutagenic impurities can be expected in any drug product; however, this is not a concern providing they are present below the safe limit. The objective of a carcinogenicity study is to identify compounds that can cause tumours in animals, which is imperative to understanding the cancer risk posed to humans.

We are absolutely thrilled to have won theTech4Good (Product) award at the 2022 Leeds Digital Festival!

Read what one of our Complex Nitrosamines Data Sharing Initiative members, Graham Smith, Oncology Chemical Toxicology Lead at AstraZeneca, has to say about being involved in this growing consortium!

Hi, my name is Raeesah and I work in the Business Partnerships Team here at Lhasa Limited!

Read on to discover what a typical day in the life of a Business Partnerships Manager working from home on a Tuesday looks like!

Evaluating the potential toxicity of chemicals is an important part of the drug development process. Optimizing a data set that provides quality over quantity is critical in the search for suitable drug candidates. 

I recently read that by 2025, 36% of world data will be healthcare data. (Yes, thirty-six percent!). Considering this statistic, now more than ever, it is important that we are working to ensure existing data is utilised to make better safety assessment decisions more quickly - whilst also relying less on animal testing.

N-Nitrosamine risk assessment and control have become an integral part of pharmaceutical drug product development. In this article, we discuss 3 key stages of risk assessment: identifying the source of risk, determining the level of activity and mitigating the risk. Discover how our in silico tools can be used to support informed decision making on chemical safety, in this blog article.

Hello, my name is Fabrizio Campo.

I work in the Software Delivery department at Lhasa Limited, as a Junior Software Developer. 

Here is my typical day as a Junior Software Developer at Lhasa Limited.

Would your toxicology assessments benefit from free access to long-term carcinogenicity study data? The Lhasa Carcinogenicity Database (LCDB) is a widely used, free resource of long-term carcinogenicity study data.

In this article we explore 5 things you should know about the data in the LCDB.